Medical Condition News

RSS

Gitelman syndrome more common in Japanese population than previously reported

Clinical Fellow KONDO Atsushi and Professor NOZU Kandai et al. of Kobe University's Graduate School of Medicine have estimated the prevalence of Gitelman syndrome across different ethnicities using a genome database.

30 Aug 2021

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal of Parkinson's Disease.

30 Aug 2021

Influenza vaccination should become a part of standard hospital care after myocardial infarction

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

How early interferon curbs SARS-CoV-2 infection

A new study available in the Journal of Experimental Medicine focuses on the importance of interferon in SARS-CoV-2 infection.

30 Aug 2021

More than 80% of hypertension cases now found in poorer countries

More than half a billion people worldwide live with undetected, untreated hypertension, even as the disease burden shifts from rich nations to poor countries with limited resources to detect and manage the condition.

30 Aug 2021

UH associate professor receives $2.5 million to explore how arterial hardening starts within cells

In diseases such as hypertension, aging, atherosclerosis, diabetes and chronic kidney disease, arterial calcification and stiffening of the elastic layer of the arterial wall are almost always present.

30 Aug 2021

Intensive blood-pressure control benefits older hypertensive patients

Aggressive blood pressure treatment in older hypertensive patients lowers the incidence of cardiovascular events compared to standard therapy, without increasing adverse outcomes. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Post mRNA-1273 vaccination rashes

A group of researchers reported that skin reactions after the administration of the mRNA-1273 vaccine are rare yet possible.

30 Aug 2021

Stenting and surgery have similar effects on stroke in patients with severe carotid artery stenosis

Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021 and published simultaneously in The Lancet.

30 Aug 2021

‘My time to live’: Through novel program, kidney patients get palliative care, dialysis ’til the end

After a decade of living with chronic kidney disease, Vonita McGee knows her body is wearing out.

30 Aug 2021

Combination therapy given in fixed doses can cut risk of cardiovascular disease by more than half

A combination therapy of aspirin, statins and at least two blood pressure medications given in fixed doses can slash the risk of fatal cardiovascular disease (CVD) by more than half, says an international study led by Hamilton researchers.

30 Aug 2021

Screening for atrial fibrillation in the elderly could help avoid stroke and death

Screening for atrial fibrillation in 75- and 76-year-olds could reduce the risk of stroke, severe bleeding and death, according to a study at Karolinska Institutet in Sweden that has been published in the journal The Lancet.

30 Aug 2021

Daily walnut consumption lowers LDL cholesterol levels and may promote cardiovascular health

Eating about ½ cup of walnuts every day for two years modestly lowered levels of low-density lipoprotein (LDL) cholesterol, known as "bad cholesterol," and reduced the number of total LDL particles and small LDL particles in healthy, older adults, according to new research published today in the American Heart Association's flagship journal Circulation.

30 Aug 2021

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).

30 Aug 2021

COVID-19 in Virginia: Beliefs drive behavior

A new paper examines this phenomenon as it relates to the state of Virginia to outline lessons to be learned from this debacle of pandemic management.

29 Aug 2021

Have SARS-CoV-2 symptoms changed in the UK population over time?

A new paper compares changes in the symptoms due to COVID-19 over the course of the pandemic.

29 Aug 2021

What might the third wave of COVID-19 in India look like?

A new study applies mathematical modeling to understand what the third wave of the pandemic might look like in India.

29 Aug 2021

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Researchers aim to better understand the population-level thrombotic risks post COVID-19 vaccination with both the ChAdOx1-S and BNT162b2 vaccines.

29 Aug 2021

$Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction$

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.

28 Aug 2021

New ESC/EACTS guidelines for the management of valvular heart disease published

The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery Guidelines for the management of valvular heart disease are published online today in European Heart Journal.

28 Aug 2021

Medical Condition News

Gitelman syndrome more common in Japanese population than previously reported

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

Influenza vaccination should become a part of standard hospital care after myocardial infarction

How early interferon curbs SARS-CoV-2 infection

More than 80% of hypertension cases now found in poorer countries

UH associate professor receives $2.5 million to explore how arterial hardening starts within cells

Intensive blood-pressure control benefits older hypertensive patients

Post mRNA-1273 vaccination rashes

Stenting and surgery have similar effects on stroke in patients with severe carotid artery stenosis

‘My time to live’: Through novel program, kidney patients get palliative care, dialysis ’til the end

Combination therapy given in fixed doses can cut risk of cardiovascular disease by more than half

Screening for atrial fibrillation in the elderly could help avoid stroke and death

Daily walnut consumption lowers LDL cholesterol levels and may promote cardiovascular health

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

COVID-19 in Virginia: Beliefs drive behavior

Have SARS-CoV-2 symptoms changed in the UK population over time?

What might the third wave of COVID-19 in India look like?

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

New ESC/EACTS guidelines for the management of valvular heart disease published

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News